摘要
伯克霍尔德菌属是一个高度多样化的种群,在各种环境和生境中广泛存在。这一种群中,以对广泛的环境条件(包括消毒剂和有机试剂)的适应力而著称,代表着一些最难治疗的感染性亚群。这个亚群包括类鼻疽伯克霍尔德菌,类鼻疽的病原体;鼻疽伯克霍尔德氏菌,类鼻疽的病原体和洋葱伯克霍尔德复合体 (Bcc) 等导致囊纤维化和免疫低下患者的机会性感染。后者病原体本身就是一个由18个不同但密切相关的物种组成的群体。这个群体的适应性允许分子毒力因子大量的选择表达来促进其在多种生境中生存。本文将描述这些与人类感染相关的选择;比较三种病原体且强调其作为候选疫苗的潜在作用。更好的整合伯克霍尔德菌群发病机制和分子毒力因子的相关知识可有利于更有效疫苗的开发。
关键词: 洋葱伯克霍尔德复合体, 鼻疽伯克霍尔德氏菌,类鼻疽伯克霍尔德菌,囊纤维化,鼻疽,类鼻疽,疫苗,毒力。
Current Medicinal Chemistry
Title:Exploiting Molecular Virulence Determinants in Burkholderia to Develop Vaccine Antigens
Volume: 22 Issue: 14
Author(s): William Thomas Casey and Siobhan McClean
Affiliation:
关键词: 洋葱伯克霍尔德复合体, 鼻疽伯克霍尔德氏菌,类鼻疽伯克霍尔德菌,囊纤维化,鼻疽,类鼻疽,疫苗,毒力。
摘要: The Burkholderia genus is a highly diverse group of species that are distributed throughout a wide range of environments and habitats. Among this group, which is remarkable for its adaptability to a wider range of environmental conditions including disinfectants and organic solvents, are a subgroup that represents some of the most difficult to treat infections. This subgroup includes Burkholderia pseudomallei, the causative agent of melioidosis; B. mallei, the causative agent of glanders and B. cepacia complex (Bcc) which causes opportunistic infections in people with cystic fibrosis and immunocompromised patients. The latter pathogen is itself a group of 18 distinct, but, closely related species. The adaptability of this group allows the expression of a rich selection of molecular virulence determinants to facilitate its survival in the diverse habitats that it colonises. This review will describe a selection of these associated with human infection; comparing them across the three pathogens and highlighting their potential roles as vaccine candidates. Better integration of the knowledge on the pathogenesis and molecular determinants of virulence for these Burkholderia spp may allow the development of more efficacious vaccines.
Export Options
About this article
Cite this article as:
William Thomas Casey and Siobhan McClean , Exploiting Molecular Virulence Determinants in Burkholderia to Develop Vaccine Antigens, Current Medicinal Chemistry 2015; 22 (14) . https://dx.doi.org/10.2174/0929867322666150408111304
DOI https://dx.doi.org/10.2174/0929867322666150408111304 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Delivery of Peptides Via the Oral Route: Diabetes Treatment by Peptide-Loaded Nanoparticles
Current Pharmaceutical Design Evidence for the Involvement of Resistin in Inflammation and Cardiovascular Disease
Current Diabetes Reviews Surgical Options for Management of Malignant Pleural Mesothelioma in the Current Era
Current Respiratory Medicine Reviews Novel Nanostructured Polymeric Carriers to Enable Drug Delivery for Cardiovascular Diseases
Current Pharmaceutical Design Lifestyle Interventions for Cardiovascular Risk Reduction in Women with Breast Cancer
Current Cardiology Reviews Pharmacology of Voltage-Gated Proton Channels
Current Pharmaceutical Design Serum Microbial- and Host-Derived Markers of Periodontal Diseases: A Review
Current Medicinal Chemistry Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs
Current Drug Metabolism New Viral Infection COVID-19: Current Status, Challenges and Possible Treatments
Letters in Drug Design & Discovery Donepezil May Reduce Insulin-Like Growth Factor-1 (IGF-1) Levels in Alzheimer’s disease
CNS & Neurological Disorders - Drug Targets Updated Acute Community-Acquired Pneumonia in Adults: Guidelines for Initial Antimicrobial Therapy Based on Local Evidence from the South American Working Group (Consensur II)
Current Respiratory Medicine Reviews Activation of the Innate Immune System in Atherosclerotic Disease
Current Pharmaceutical Design Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Modulating the Hypoxia-Inducible Factor Signaling Pathway: Applications From Cardiovascular Disease to Cancer
Current Pharmaceutical Design Clinical Assessment of Autonomic Function in Fibromyalgia by the Refined and Abbreviated Composite Autonomic Symptom Score (COMPASS 31): A Case-Controlled Study
Reviews on Recent Clinical Trials Cardiovascular Morbidity and Mortality in Obstructive Sleep Apnea
Current Pharmaceutical Design Occupational Risk Assessment of Engineered Nanomaterials: Limits, Challenges and Opportunities
Current Nanoscience An Overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases
Mini-Reviews in Medicinal Chemistry Practical Considerations in the Development of Hemoglobin-Based Oxygen Therapeutics
Current Drug Discovery Technologies Metabolomics of Serum Peptides
Protein & Peptide Letters